Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Kerr

Showing results (691-700 of 966) with videos related to

Pageof 97
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targetsJoseph A Wahle, Kim H T Paraiso, Amy L Costello, et al.
Molecular Therapy. Nucleic Acids|November 9, 2016
Episomal Nonviral Gene Therapy Vectors Slow Progression of Atherosclerosis in a Model of Familial HypercholesterolemiaAlastair G Kerr, Lawrence Cs Tam, Ashley B Hale, et al.
Calcified Tissue International|July 12, 2012
Molecular mechanisms of vitamin D actionMark R Haussler, G Kerr Whitfield, Ichiro Kaneko, et al.
Biomedicines|April 23, 2022
A Novel Approach to Enhance the Regenerative Potential of Circulating Endothelial Progenitor Cells in Patients with End-Stage Kidney DiseaseAmrilmaen Badawi, Osfred C Jefferson, Brooke M Huuskes, et al.
Organic & Biomolecular Chemistry|May 4, 2022
Synthetic studies on the indane SHIP1 agonist AQX-1125Otto M Dungan, Shawn Dormann, Sandra Fernandes, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 11, 2015
Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis PopulationMark R Marshall, Kevan R Polkinghorne, Peter G Kerr, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trialsRobert S Flanc, Matthew A Roberts, Giovanni F M Strippoli, et al.
The Cochrane Database of Systematic Reviews|February 20, 2004
Treatment for lupus nephritisR S Flanc, M A Roberts, G F M Strippoli, et al.
Genes and Immunity|March 7, 2014
SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammationM J Maxwell, N Srivastava, M-Y Park, et al.
Internal Medicine Journal|March 20, 2010
Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation TrialS Zoungas, M Lui, P G Kerr, et al.
Pageof 97

Showing results (691-700 of 966) with videos related to

Sort By:
Pageof 97
Journal of Immunology (Baltimore, Md. : 1950)|June 6, 2006
Cutting edge: dominance by an MHC-independent inhibitory receptor compromises NK killing of complex targetsJoseph A Wahle, Kim H T Paraiso, Amy L Costello, et al.
Molecular Therapy. Nucleic Acids|November 9, 2016
Episomal Nonviral Gene Therapy Vectors Slow Progression of Atherosclerosis in a Model of Familial HypercholesterolemiaAlastair G Kerr, Lawrence Cs Tam, Ashley B Hale, et al.
Calcified Tissue International|July 12, 2012
Molecular mechanisms of vitamin D actionMark R Haussler, G Kerr Whitfield, Ichiro Kaneko, et al.
Biomedicines|April 23, 2022
A Novel Approach to Enhance the Regenerative Potential of Circulating Endothelial Progenitor Cells in Patients with End-Stage Kidney DiseaseAmrilmaen Badawi, Osfred C Jefferson, Brooke M Huuskes, et al.
Organic & Biomolecular Chemistry|May 4, 2022
Synthetic studies on the indane SHIP1 agonist AQX-1125Otto M Dungan, Shawn Dormann, Sandra Fernandes, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 11, 2015
Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis PopulationMark R Marshall, Kevan R Polkinghorne, Peter G Kerr, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 30, 2004
Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trialsRobert S Flanc, Matthew A Roberts, Giovanni F M Strippoli, et al.
The Cochrane Database of Systematic Reviews|February 20, 2004
Treatment for lupus nephritisR S Flanc, M A Roberts, G F M Strippoli, et al.
Genes and Immunity|March 7, 2014
SHIP-1 deficiency in the myeloid compartment is insufficient to induce myeloid expansion or chronic inflammationM J Maxwell, N Srivastava, M-Y Park, et al.
Internal Medicine Journal|March 20, 2010
Advanced chronic kidney disease, cardiovascular events and the effect of diabetes: data from the Atherosclerosis and Folic Acid Supplementation TrialS Zoungas, M Lui, P G Kerr, et al.
Pageof 97